Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Coagulation profile in pathophysiology of sickle cell anemia

Shehin M, Kanhu Charan Purohit, Sunil Kumar Jena, Basila V.




Abstract

Background: Sickle cell anemia (SCA) is an emerging public health challenge in India as well as globally. The WHO recognized it as a global problem since long time. In Western Odisha, its prevalence varies from 5% to 30%.

Aim and Objective: The objective of this study was to determine the alteration of the coagulation profile in SCA in comparison to healthy control.

Materials and Methods: This study was completed with 60 subjects that included 30 cases and 30 controls. This study was approved by the Institutional Ethical Committee. The hematological parameters such as bleeding time, clotting time, total platelet count, prothrombin time (PT), and activated partial thromboplastin time (aPTT) were tested. The data were analyzed through SPSS 20.

Results: In this study, it was found that patients with SCA have increased clotting time (P = 0.007), PT (P = 0.000), aPTT (P = 0.003), and total platelet count (P = 0.183), but decreased bleeding time (P = 0.000) in comparison to healthy control.

Conclusion: We found a significant increase in clotting time, PT, and aPTT, but decrease in bleeding time in SCA patients in comparison to healthy adults.

Key words: Coagulation profile; Sickle cell anemia; Hypercoagulability






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.